Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock
AssigneeDynebio Inc.
InventorsJe Hyeon Lee, Moon Hee Lee, Sun Joo Hong, Soon Kwang Hong
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement.
Claims7
A method for treating sepsis or septic shock in a subject, the method comprising administering to the subject a neoagarooligosaccharide, wherein the neoagarooligosaccharide is prepared from agar or agarose by an agarase gene (DagA) enzyme reaction wherein the DagA enzyme is obtained from Streptomyces coelicolor.
Dependencies are inferred from the claim text.